Skip to Content

Rule

Withdrawal of Approval of New Animal Drug Applications; Quali-Tech Products, Inc.; Bambermycins; Pyrantel; Tylosin; Virginiamycin

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Final rule.

SUMMARY:

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the withdrawal of approval of four new animal drug applications (NADAs), held by Quali-Tech Products, Inc., at the sponsor's request because the products are no longer manufactured or marketed.

DATES:

The rule is effective September 3, 2013.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

David Alterman, Center for Veterinary Medicine (HFV-212), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-453-6843, david.alterman@fda.hhs.gov.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

Quali-Tech Products, Inc., has requested that FDA withdraw approval of the following four NADAs because the products, used to manufacture Type C medicated feeds, are no longer manufactured or marketed: NADA 097-980 for Quali-Tech TYLAN-10 (tylosin phosphate) Premix, NADA 118-815 for Q.T. BAN-TECH (pyrantel tartrate), NADA 132-705 for FLAVOMYCIN (bambermycins), and NADA 133-335 for STAFAC (virginiamycin) Swine Pak 10.

Elsewhere in this issue of the Federal Register, FDA gave notice that approval of NADAs 097-980, 118-815, 132-705, and 133-335, and all supplements and amendments thereto, is withdrawn. As provided in the regulatory text of this document, the animal drug regulations are amended to reflect these voluntary withdrawals of approval.

Following these withdrawals of approval, Quali-Tech Products, Inc., will no longer be the sponsor of an approved application. Accordingly, 21 CFR 510.600(c) is being amended to remove the entries for this firm.

This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.

Start List of Subjects

List of Subjects

End List of Subjects

Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 510 and 558 are amended as follows:

Start Part

PART 510—NEW ANIMAL DRUGS

End Part Start Amendment Part

1. The authority citation for

End Amendment Part Start Authority

Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.

End Authority
[Amended]
Start Amendment Part

2. In § 510.600, in the table in paragraph (c)(1), remove the entry for “Quali-Tech Products, Inc.”; and in the table in paragraph (c)(2), remove the entry for “016968”.

End Amendment Part Start Part

PART 558—NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS

End Part Start Amendment Part

3. The authority citation for

End Amendment Part Start Authority

Authority: 21 U.S.C. 360b, 371.

End Authority Start Amendment Part

4. In § 558.95, revise paragraphs (a), (d)(1), (d)(2), (d)(3), (d)(4)(i), and (d)(4)(ii) to read as follows:

End Amendment Part
Bambermycins.

(a) Approvals. See sponsors in § 510.600(c) of this chapter for use of Type A medicated articles as in paragraph (d) of this section:

(1) No. 016592: 2, 4, and 10 grams per pound for use as in paragraphs (d)(1), (d)(2), (d)(3), and (d)(4) of this section.

(2) Nos. 012286 and 017790: 2 grams for use as in paragraph (d)(2) of this section and 0.4 and 2 grams per pound for use as in paragraph (d)(3).

* * * * *

(d) * * *

(1) Chickens. Use in medicated feed as follows:

Bambermycins in grams/tonIndications for useLimitationsSponsor
(i) 1 to 2Broiler chickens: For increased rate of weight gain and improved feed efficiencyFeed continuously as the sole ration016592.
(ii) [Reserved]

(2) Turkeys. Use in medicated feed as follows:

Bambermycins in grams/tonIndications for useLimitationsSponsor
(i) 1 to 2Growing turkeys: For improved feed efficiencyFeed continuously as the sole ration012286, 016592, 017790.
(ii) 2Growing turkeys: For increased rate of weight gain and improved feed efficiencyFeed continuously as the sole ration012286, 016592, 017790.
Start Printed Page 52431

(3) Swine. Use in medicated feed as follows:

Bambermycins in grams/tonIndications for useLimitationsSponsor
(i) 2Growing-finishing swine: For increased rate of weight gain and improved feed efficiencyFeed continuously as the sole ration012286, 016592, 017790.
(ii) 2 to 4Growing-finishing swine: For increased rate of weightFeed continuously as the sole ration012286, 016592, 017790.

(4) Cattle. Use in medicated feed as follows:

Bambermycins in grams/tonIndications for useLimitationsSponsor
(i) 1 to 4Cattle fed in confinement for slaughter: For increased rate of weight gain and improved feed efficiencyFeed continuously at a rate of 10 to 20 milligrams per head per day016592.
(ii) 2 to 40Pasture cattle (slaughter, stocker, and feeder cattle, and dairy and beef replacement heifers): For increased rate of weight gainFeed continuously at a rate of 10 to 40 milligrams per head per day in at least 1 pound and not more than 10 pounds of feed. Daily bambermycins intakes in excess of 20 mg/head/day have not been shown to be more effective than 20 mg/head/day016592.
* * * * *
[Amended]
Start Amendment Part

5. In paragraph (b)(3) of § 558.485, remove “Nos. 016968, and 017790” and in its place add “No. 017790”.

End Amendment Part
[Amended]
Start Amendment Part

6. In § 558.625, remove and reserve paragraph (b)(14).

End Amendment Part
[Amended]
Start Amendment Part

7. In paragraph (a)(2) of § 558.635, remove “046573, 016968, and 017790” and in its place add “046573 and 017790”.

End Amendment Part Start Signature

Dated: August 20, 2013.

Bernadette Dunham,

Director, Center for Veterinary Medicine.

End Signature End Supplemental Information

[FR Doc. 2013-20616 Filed 8-22-13; 8:45 am]

BILLING CODE 4160-01-P